Skip to main content
. 2023 Nov 16;9:7. doi: 10.1186/s40842-023-00156-3

Table 2.

Primary and secondary outcomes according to HOMA-IR groups

HOMA-IR groups
Low (n = 1454) Moderate (n = 1414) High (n = 1446) p-value p’ p”
New onset Diabetes 43 (3.0) 37 (2.6) 84 (5.8) < 0.001 < 0.001 < 0.001
Chronic kidney disease 123 (8.5) 129 (9.3) 173 (12.2) 0.002 0.001 0.007
Macrovascular events 41 (2.9) 26 (1.8) 35 (2.4) 0.156 0.407 0.263
Coronary artery disease or MI 29 (2.0) 15 (1.5) 20 (1.4) 0.052 0.095 0.610
Ischemic stroke 12 (0.8) 11 (0.8) 15 (1.0) 0.809 0.707 0.511

Values are presented as number (%), p-values were calculated using Kaplan–Meier survival analysis with the log rank test. P′ is for the comparison between the low and high HOMA-IR groups. p” is for the comparison between the moderate and high HOMA-IR groups